BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $12.98 million. The enterprise value is $5.60 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 8.66 million shares outstanding. The number of shares has increased by 38.60% in one year.
| Current Share Class | 8.66M |
| Shares Outstanding | 8.66M |
| Shares Change (YoY) | +38.60% |
| Shares Change (QoQ) | +4.59% |
| Owned by Insiders (%) | 16.98% |
| Owned by Institutions (%) | 2.93% |
| Float | 6.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.67 |
| Forward PS | 5.91 |
| PB Ratio | 2.48 |
| P/TBV Ratio | 3.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.07
| Current Ratio | 2.07 |
| Quick Ratio | 2.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -137.09% and return on invested capital (ROIC) is -104.03%.
| Return on Equity (ROE) | -137.09% |
| Return on Assets (ROA) | -66.42% |
| Return on Invested Capital (ROIC) | -104.03% |
| Return on Capital Employed (ROCE) | -270.16% |
| Revenue Per Employee | $55,018 |
| Profits Per Employee | -$974,875 |
| Employee Count | 11 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.85% in the last 52 weeks. The beta is 0.06, so BRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -3.85% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 42.89 |
| Average Volume (20 Days) | 304,985 |
Short Selling Information
The latest short interest is 124,671, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 124,671 |
| Short Previous Month | 113,658 |
| Short % of Shares Out | 1.44% |
| Short % of Float | 1.99% |
| Short Ratio (days to cover) | 1.73 |
Income Statement
In the last 12 months, BRTX had revenue of $605,200 and -$10.72 million in losses. Loss per share was -$1.29.
| Revenue | 605,200 |
| Gross Profit | 571,980 |
| Operating Income | -13.09M |
| Pretax Income | -10.72M |
| Net Income | -10.72M |
| EBITDA | -12.89M |
| EBIT | -13.09M |
| Loss Per Share | -$1.29 |
Full Income StatementBalance Sheet
The company has $7.38 million in cash and n/a in debt, giving a net cash position of $7.38 million or $0.85 per share.
| Cash & Cash Equivalents | 7.38M |
| Total Debt | n/a |
| Net Cash | 7.38M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 4.85M |
| Book Value Per Share | 0.61 |
| Working Capital | 3.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.52 million and capital expenditures -$107,293, giving a free cash flow of -$9.63 million.
| Operating Cash Flow | -9.52M |
| Capital Expenditures | -107,293 |
| Free Cash Flow | -9.63M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
| Gross Margin | 94.51% |
| Operating Margin | -2,162.91% |
| Pretax Margin | -1,771.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.60% |
| Shareholder Yield | -38.60% |
| Earnings Yield | -82.59% |
| FCF Yield | -74.15% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 256.89% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4,000 |
Scores
BRTX has an Altman Z-Score of -29.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.38 |
| Piotroski F-Score | 2 |
